Fig. 2From: Association of glucagon-like peptide-1 receptor agonists with cardiac arrhythmias in patients with type 2 diabetes or obesity: a systematic review and meta-analysis of randomized controlled trialsRisk of cardiac arrhythmias in patients randomized to GLP-1 RAs treatment compared with controls across all trials. GLP-1 RAs glucagon-like peptide 1 receptor agonists, CI confidence intervalBack to article page